Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2024-08-15 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
关于公司高级管理人员变更的公告
Board/Management Information Classification · 100% confidence The document is a short announcement (431 characters) regarding a change in senior management personnel of the company 大博医疗科技股份有限公司. It specifically states that a senior management member, 韩少坚, is no longer serving as a senior manager due to job adjustment but remains with the company in another role. There is no financial data, no mention of financial results, no audit information, or other report types. The content fits the description of 'Board/Management Information' which covers announcements of changes in the company's board of directors or senior management. The document is not a report or a regulatory filing but a direct announcement of management change.
2024-08-15 Chinese
关于修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement from a company about revisions to its Articles of Association (公司章程). It details specific amendments to the company's bylaws, including share repurchase conditions and dividend policies. The document references legal and regulatory frameworks and states that the amendments will be submitted for shareholder approval at an upcoming extraordinary general meeting. The document is relatively short (2577 characters) and does not contain financial statements or detailed financial data. It is not a full report but an announcement of changes to governance documents. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-08-15 Chinese
关于北京安德思考普科技有限公司业绩承诺完成情况的鉴证报告
Regulatory Filings
2024-08-15 Chinese
大博医疗科技股份有限公司2023年年度报告（更新后）
Annual Report Classification · 100% confidence The document is titled "大博医疗科技股份有限公司2023 年年度报告全文" which translates to "Double Medical Technology Inc. 2023 Annual Report Full Text." It contains detailed sections including company overview, financial data, management discussion and analysis, governance, environmental and social responsibility, important matters, shareholder information, bond information, and financial statements. The document includes comprehensive financial data, management analysis, accounting policies, and audit information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed financial statements and management discussion confirms it is the official annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-08-15 Chinese
关于2023年年度报告的更正公告
Regulatory Filings Classification · 95% confidence The document is titled as a correction announcement related to the company's 2023 Annual Report. It specifically mentions corrections to the financial report section of the 2023 Annual Report, indicating it is not the full annual report itself but a notice correcting previously disclosed annual report data. The document length is short (2189 characters), and it states that other contents of the 2023 Annual Report remain unchanged. This fits the pattern of a report correction or announcement rather than the full report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a correction announcement related to a regulatory disclosure, not the full Annual Report (10-K).
2024-08-15 Chinese
大博医疗科技股份有限公司2024年第三次独立董事专门会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the independent directors' special meeting of the company, discussing the review and approval of related party transactions for the years 2021-2024. It includes details about the meeting's convening, attendance, and voting results. The content focuses on governance and compliance with laws and regulations regarding related party transactions. It does not contain financial statements or detailed financial performance data, nor is it an announcement of a report publication. The document is best classified under Board/Management Information (MANG) as it relates to board-level decisions and governance matters.
2024-08-15 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.